Trek Financial’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,135	Closed	-$246K	–	445
2024 Q3	$246K	Buy	2,135 +466	+28%	+$53.7K	0.02%	343
2024 Q2	$230K	Sell	1,669 -388	-19%	-$53.4K	0.02%	349
2024 Q1	$284K	Buy	+2,057	New	+$284K	0.02%	319